Peptide Storage Guide — How to Store, Freeze & Reconstitute Research Compounds
A complete guide to maintaining peptide integrity from delivery to use — covering lyophilised storage, reconstitution technique, and post-reconstitution handling.
Proper storage and handling is the single most important variable within a researcher’s control when working with peptide compounds. Degradation from incorrect storage is irreversible and undetectable by visual inspection alone — a peptide solution can appear perfectly clear while having lost significant biological activity. This guide covers the complete chain from receipt to use.
The Basics: Why Peptides Degrade
Peptides are chains of amino acids held together by peptide bonds. These bonds — and the three-dimensional folded structure of the peptide — can be disrupted by:
- Heat: Accelerates chemical degradation and oxidation. Even room temperature (~20°C) causes measurable degradation over days for most peptides.
- Freeze-thaw cycling: Repeated freezing and thawing creates ice crystals that disrupt peptide structure and cause aggregation.
- Light: UV exposure can cause photo-oxidation, particularly of methionine and tryptophan residues.
- Moisture (before reconstitution): Water initiates hydrolysis of peptide bonds in lyophilised powder.
- Microbial contamination: Bacteria produce proteases that degrade peptides rapidly.
Storing Lyophilised (Dry) Powder
Peptides arrive in lyophilised form — a freeze-dried powder that is far more stable than reconstituted solution. With proper storage, lyophilised peptides can remain stable for 12-24 months.
Keep sealed until ready to reconstitute
The lyophilised vial is sealed under nitrogen or vacuum. Do not puncture the stopper until you are ready to use the compound — once opened, the powder is exposed to ambient humidity and begins to absorb moisture.
Store at -20°C in the freezer
Place vials in a sealed bag or container to prevent frost accumulation. Most peptides are stable at -20°C for 12-24 months. For long-term archival storage beyond 12 months, -80°C is preferred where available.
Protect from light
Store in the original packaging or wrapped in foil. Amber vials provide some UV protection; clear vials do not. Keep away from windows and fluorescent lighting.
Allow to reach room temperature before opening
Remove from freezer 15-20 minutes before use. This prevents condensation from forming inside the vial when it is punctured — moisture contamination can accelerate degradation.
Reconstitution — Step by Step
Reconstitution is the process of dissolving lyophilised powder in bacteriostatic water to create a stable solution at a known concentration.
Calculate your target concentration first
Decide how much BAC water to add based on your desired concentration. Example: adding 2ml to a 5mg vial gives 2.5mg/ml (2500mcg/ml). Adding 1ml gives 5mg/ml. More water = lower concentration = larger injection volumes per dose unit.
Wipe stoppers with alcohol swabs
Wipe both the peptide vial stopper and the BAC water vial stopper with separate alcohol swabs. Allow to dry fully (30 seconds) before proceeding — wet alcohol can contaminate the solution.
Draw the BAC water slowly
Insert the needle into the BAC water vial and draw up your calculated volume. Minimise air bubbles by drawing slowly.
Add water to peptide — aim at the glass wall
Insert the needle into the peptide vial at an angle. Direct the BAC water toward the glass wall rather than straight onto the powder. This prevents foaming and mechanical disruption of the peptide structure.
Do not shake — gently swirl or roll
Never shake a peptide vial. Shaking causes foaming and can disrupt the peptide structure through mechanical agitation. Instead, gently roll the vial between your palms or swirl in slow circles until fully dissolved.
Inspect the solution
The reconstituted solution should be clear and colourless (some peptides may have a very slight yellow tint — this is normal). Cloudiness, particulates, or unusual colour indicate potential degradation or contamination — do not use.
Storing Reconstituted Solutions
| Storage Condition | Lyophilised Powder | Reconstituted Solution |
|---|---|---|
| Room temperature (20°C) | Days to weeks (not recommended) | Hours only — avoid* |
| Refrigerated (2-8°C) | Weeks (short term only) | Up to 4 weeks with BAC water |
| Frozen (-20°C) | 12-24 months | 3-6 months (avoid repeated freeze-thaw) |
| Deep frozen (-80°C) | 2+ years | 6-12 months |
* Our pre-filled pens and cartridges are the exception: they’re usually fine at room temperature for up to 21 days. Keep them refrigerated as much as possible all the same — see Pen Cartridges & Disposable Pens below.
Freeze-Thaw Management for Reconstituted Solutions
If you need to store reconstituted solution for extended periods, aliquoting (dividing into single-use portions) before freezing prevents repeated freeze-thaw degradation:
- After reconstitution, draw into multiple small syringes (e.g. 10 x 0.1ml aliquots)
- Cap each syringe and label with compound, concentration and date
- Freeze immediately at -20°C
- Thaw one aliquot at a time — use the same day, do not refreeze
Pen Cartridges & Disposable Pens
Pre-filled cartridges and disposable pens contain reconstituted solution, so keep them refrigerated at 2-8°C as much as possible when not in use, away from light and heat, and use within the manufacturer’s recommended window (up to 3 months from first use for cartridges or pens).
Our pens and cartridges are usually fine at room temperature for up to 21 days, so time in the post or a spell out of the fridge won’t affect their quality. Get them back into the fridge as soon as you can.
The Science of Peptide Degradation
Formulation research on therapeutic peptides and proteins identifies a small number of chemical and physical pathways behind most stability losses. Knowing which apply to a given sequence helps explain the storage rules above.
| Pathway | Most vulnerable residues | Accelerated by | Practical mitigation |
|---|---|---|---|
| Deamidation | Asparagine (especially Asn-Gly) and glutamine | Neutral–alkaline pH, heat, time in solution | Keep dry and cold; minimise time reconstituted |
| Oxidation | Methionine, cysteine, tryptophan, histidine | Light, dissolved oxygen, trace metals | Protect from light; limit air exposure and repeated puncture |
| Peptide-bond cleavage | Aspartate-proline and aspartate-glycine bonds | Acidic pH, moisture | Keep lyophilised powder sealed and dry |
| Aggregation | Hydrophobic or high-concentration preparations | Agitation, freeze–thaw, some preservatives | Swirl, don’t shake; aliquot to avoid repeat freezing |
| Solid-state degradation | Any lyophilised peptide | Residual or absorbed moisture, heat | Warm to room temperature before opening; store desiccated |
Key Published Research
- Lyophilised stability (1999): A review of solid-state stability showed that moisture content and temperature are the dominant drivers of chemical degradation in freeze-dried proteins and peptides — the scientific basis for keeping vials sealed, cold and dry.1
- Freeze–thaw rates (2003): The rates of both freezing and thawing affected how much protein activity was lost, supporting single-cycle, aliquoted freeze–thaw handling.2
- Benzyl alcohol and aggregation (2005): The preservative benzyl alcohol accelerated aggregation of a reconstituted lyophilised protein formulation — a reminder that bacteriostatic water is not ideal for every compound, especially aggregation-prone ones used within a single session.3
- Preservatives in multi-dose products (2007): A review of antimicrobial preservatives in parenteral products describes benzyl alcohol as one of the most widely used, and explains why multi-dose containers need one.4
- Stability pathways (2010): A comprehensive update on protein and peptide stability covering deamidation, oxidation, hydrolysis and aggregation mechanisms.5
Evidence Quality & Limitations
Most published stability data come from pharmaceutical formulation science rather than from the specific research peptides on this site, and stability depends heavily on sequence, salt form, pH and concentration. The storage durations in the table above are general guidance, not compound-specific stability data. Where a certificate of analysis or supplier stability data exist for a batch, those take precedence.
References
- Lai MC, Topp EM. Solid-state chemical stability of proteins and peptides. J Pharm Sci. 1999;88:489–500. PubMed
- Cao E, et al. Effect of freezing and thawing rates on denaturation of proteins in aqueous solutions. Biotechnol Bioeng. 2003;82:684–90. PubMed
- Roy S, et al. Effects of benzyl alcohol on aggregation of recombinant human interleukin-1-receptor antagonist in reconstituted lyophilized formulations. J Pharm Sci. 2005;94:382–96. PubMed
- Meyer BK, et al. Antimicrobial preservative use in parenteral products: past and present. J Pharm Sci. 2007;96:3155–67. PubMed
- Manning MC, et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27:544–75. PubMed
